| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |